# Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC

> **NCT06120374** · — · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 178 (estimated)

## Conditions studied

- Urothelial Carcinoma

## Interventions

- **RADIATION:** Radiotherapy
- **DRUG:** Chemotherapy
- **DRUG:** Immunotherapy

## Key facts

- **NCT ID:** NCT06120374
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2027-06-08
- **Final completion:** 2029-06-08
- **Target enrollment:** 178 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06120374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06120374, "Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT06120374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*